These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1407599)

  • 1. Baclofen for spasticity.
    Landau WM; Feldman RG
    Neurology; 1992 Oct; 42(10):2056. PubMed ID: 1407599
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of baclofen in treatment of spasticity in multiple sclerosis.
    Sawa GM; Paty DW
    Can J Neurol Sci; 1979 Aug; 6(3):351-4. PubMed ID: 385132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tizanidine versus baclofen in the treatment of spasticity in multiple sclerosis patients.
    Hoogstraten MC; van der Ploeg RJ; vd Burg W; Vreeling A; van Marle S; Minderhoud JM
    Acta Neurol Scand; 1988 Mar; 77(3):224-30. PubMed ID: 3376747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up.
    Rekand T; Grønning M
    J Rehabil Med; 2011 May; 43(6):511-4. PubMed ID: 21533331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients.
    Ben Smail D; Peskine A; Roche N; Mailhan L; Thiébaut I; Bussel B
    Mult Scler; 2006 Feb; 12(1):101-3. PubMed ID: 16459726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of spasticity by intrathecal baclofen treatment].
    Helén P; Kuurne T
    Duodecim; 1993; 109(14):1251-5. PubMed ID: 8062701
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrathecal baclofen in multiple sclerosis.
    Stevenson VL
    Eur Neurol; 2014; 72 Suppl 1():32-4. PubMed ID: 25278123
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
    Draulans N; Vermeersch K; Degraeuwe B; Meurrens T; Peers K; Nuttin B; Kiekens C
    Clin Rehabil; 2013 Dec; 27(12):1137-43. PubMed ID: 23858524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose oral baclofen: experience in patients with multiple sclerosis.
    Smith CR; LaRocca NG; Giesser BS; Scheinberg LC
    Neurology; 1991 Nov; 41(11):1829-31. PubMed ID: 1944915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baclofen.
    Young RR
    Arch Neurol; 1977 Nov; 34(11):722. PubMed ID: 911241
    [No Abstract]   [Full Text] [Related]  

  • 11. Intrathecal baclofen for muscle spasticity and pain--two case reports.
    Al Khudhairi D; Rababa A; Saddiqui MN
    Middle East J Anaesthesiol; 2006 Jun; 18(5):971-6. PubMed ID: 17094537
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term effects of intrathecal baclofen in multiple sclerosis.
    Natale M; D'Oria S; Nero VV; Squillante E; Gentile M; Rotondo M
    Clin Neurol Neurosurg; 2016 Apr; 143():121-5. PubMed ID: 26922704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.
    Stampacchia G; Gerini A; Mazzoleni S
    NeuroRehabilitation; 2016 Apr; 38(4):385-93. PubMed ID: 27061166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal baclofen therapy for spastic hypertonia.
    Ivanhoe CB; Tilton AH; Francisco GE
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):923-38, viii-ix. PubMed ID: 11727722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal baclofen for treatment of intractable spinal spasticity.
    Abel NA; Smith RA
    Arch Phys Med Rehabil; 1994 Jan; 75(1):54-8. PubMed ID: 8291963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lasting reduction of severe spasticity after ending chronic treatment with intrathecal baclofen.
    Dressnandt J; Conrad B
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):168-73. PubMed ID: 8708647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal baclofen: does tolerance occur?
    Akman MN; Loubser PG; Donovan WH; O'Neill ME; Rossi CD
    Paraplegia; 1993 Aug; 31(8):516-20. PubMed ID: 8414636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity.
    Saltuari L; Kronenberg M; Marosi MJ; Kofler M; Russegger L; Rifici C; Bramanti P; Gerstenbrand F
    Acta Neurol (Napoli); 1992 Jun; 14(3):187-94. PubMed ID: 1442217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome and complications of intrathecal baclofen pump in multiple sclerosis patients: a retrospective study.
    Khan AA; Birks-Agnew I; Bullock P; Rushton D
    NeuroRehabilitation; 2010; 27(2):117-20. PubMed ID: 20871140
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intrathecal baclofen in severe spasticity due to multiple sclerosis].
    Sławek J; Zieliński P; Hołub-Kucharska W; Kaniszewska J; Paczkowska M; Słoniewski P
    Neurol Neurochir Pol; 2003; 37(5):1135-42; discussion 1143. PubMed ID: 15174259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.